Classification of substances and mixtures with endocrine disruption properties
On 31st March 2023, the European Commission published an amendment related to Regulation (EC) No 1272/2008 on the classification, labelling and packaging of substances and mixtures with endocrine-disrupting properties.
These substances and mixtures with endocrine-disrupting properties pose a concern to public health and the environment. It has been proven that endocrine disruption can lead to certain disorders in humans, among others birth defects; developmental, reproductive or neurodevelopmental disorders; cancer; diabetes; and obesity. These disorders have a high and increasing incidence in both children, adults and animals.
This situation creates the need to establish a legal hazard identification, with classes of danger, indications of danger, pictograms and category codes, and amendment of annexes I, II, III and VI of Regulation (EC) No 1272/2008 related to the substances and mixtures with these types of properties.
It amends the following annexes to Regulation (EC) No 1272/2008, which relate to Endocrine disruption:
- Annex I – Classification and labelling requirements for hazardous substances and mixtures
- Annex II – Special rules for labelling and packaging of certain substances and mixtures
- Annex III – List of hazard statements, supplemental hazard information and supplemental label elements
- Annex VI – Harmonized classification and labelling for certain hazardous substances
For more information, consult the European Commission publication here.
Eurofins Chem-ST™ hazardous smart chemical testing service offers a comprehensive solution to manage chemicals of concern across your supply chain.
Cosmetics & Personal Care
Identifying PFAS in your cosmetic and packaging products
Per- and Polyfluoroalkyl Substances (PFAS) are a large group of manufactured compounds that are used in a wide range of industrial and consumer applications, including cosmetic products. PFAS are often deliberately added as ingredients in some cosmetic products to help condition and smooth the skin, make it appear shiny, alter product consistency and texture, etc. In addition, they might be present as unintended degradation products or impurities resulting from the production of PFAS precursors used in certain cosmetic products. Some of them are considered toxic and could be absorbed by and accumulate in the human body for a long time, acting as so-called ‘forever chemicals’ with adverse health effects.
Many countries are leading the way in eliminating PFAS from cosmetic and packaging products. PFAS methodologies and regulations continually evolve as additional compounds are identified, and local regulations continue to expand their testing requirements for these contaminants. With our dedicated teams, Eurofins network of laboratories is able to offer you the flexibility to develop a testing plan and adapt to the continually changing analytical needs. With more than 20 years of experience, we are able to test a wide range of matrices for up to 75 PFAS compounds, with a breadth of equipment dedicated to PFAS analysis and LOQ/LOD capabilities.